Superior vena cava syndrome: a consecutive case series of in-hospital patients in a tertiary teaching hospital
Article Sidebar
Main Article Content
Abstract
Introduction: superior vena cava syndrome results from an obstruction of blood flow through this vessel. Currently, almost all cases are associated with malignancies. There are controversies about the optimal management of this syndrome. Endovascular therapies are considered the first-line therapy.
Material and methods: we collected clinical, laboratory and pharmacological data from patients admitted at the Hospital Italiano de Buenos Aires, between January 1st and November 1st 2021 with a diagnosis o superior vein cava syndrome. Baseline characteristics, treatment strategies and clinical outcomes were recorded.
Results: a total of five patients were included in the present study. All cases were malignancy-related. Most of the patientsdeveloped moderate symptoms. Four out of five patients were treated with endovascular therapies and two patients died during hospitalization.
Discussion: controversies regarding optimal management of the superior vena cava syndrome remain. Future research should focus on identifying those patients who are most likely to benefit from endovascular, anticoagulant or antiplatelet therapeutic strategies.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356(18):1862-1869. https://doi.org/10.1056/NEJMcp067190. Errata en: N Engl J Med. 2008;358(10):1083. DOI: https://doi.org/10.1056/NEJMcp067190
Danias PG, Pipilis AG. Superior vena cava syndrome: 1757-2007. Hellenic J Cardiol. 2007;48(6):366-367.
Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol. 2008;3(8):811-814. https://doi.org/10.1097/JTO.0b013e3181804791. DOI: https://doi.org/10.1097/JTO.0b013e3181804791
Holliday EB, Hampton DA, Thomas CR Jr, et al. Prognostic value of the Yale Grading System for superior vena cava syndrome. Ann Am Thorac Soc. 2016 Oct;13(10):1862-1865. https://doi.org/10.1513/AnnalsATS.201605-412LE.
Cohen R, Mena D, Carbajal-Mendoza R, et al. Superior vena cava syndrome: a medical emergency? Int J Angiol. 2008;17(1):43-46. https://doi.org/10.1055/s-0031-1278280. DOI: https://doi.org/10.1055/s-0031-1278280
Schraufnagel DE, Hill R, Leech JA, et al. Superior vena caval obstruction: is it a medical emergency? Am J Med. 1981;70(6):1169-1174. https://doi.org/10.1016/0002-9343(81)90823-8. DOI: https://doi.org/10.1016/0002-9343(81)90823-8
García Mónaco R, Bertoni H, Pallota G, et al. Use of self-expanding vascular endoprostheses in superior vena cava syndrome. Eur J Cardiothorac Surg. 2003;24(2):208-211. https://doi.org/10.1016/s1010-7940(03)00293-8. DOI: https://doi.org/10.1016/S1010-7940(03)00293-8
Friedman T, Quencer KB, Kishore SA, et al. Malignant venous obstruction: superior vena cava syndrome and beyond. Semin Intervent Radiol. 2017;34(4):398-408. https://doi.org/10.1055/s-0037-1608863. DOI: https://doi.org/10.1055/s-0037-1608863
Loeffler JS, Leopold KA, Recht A, et al. Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome. J Clin Oncol. 1986;4(5):716-721. https://doi.org/10.1200/JCO.1986.4.5.716. DOI: https://doi.org/10.1200/JCO.1986.4.5.716
Nicholson AA, Ettles DF, Arnold A, et al. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol. 1997;8(5):781-788. https://doi.org/10.1016/s1051-0443(97)70660-2. DOI: https://doi.org/10.1016/S1051-0443(97)70660-2
Azizi AH, Shafi I, Zhao M, et al. Endovascular therapy for superior vena cava syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;37:100970. https://doi.org/10.1016/j.eclinm.2021.100970. DOI: https://doi.org/10.1016/j.eclinm.2021.100970
Fagedet D, Thony F, Timsit JF, et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36(1):140-149. https://doi.org/10.1007/s00270-011-0310-z DOI: https://doi.org/10.1007/s00270-011-0310-z